Diabetes Quality Improvement Program on Diabetes Case Management Program 2001 (DQIP-DCMP)

May 9, 2007 updated by: China Medical University Hospital

In order to assess more completely the levels of diabetes care delivered in Taiwan, we now have nationally standardized performance measures that can evaluate quality of diabetes care accurately and reliably. These performance measures were seriously reviewed and discussed in the aspects of their practicability, feasibility and compliancy, through a series of nation-wide consensus meetings by a number of multidisciplinary professionals of Taiwan Diabetes Care Teams ( TDCTs ), before delivering into the clinical settings ( 10 ).

Conceptually, these measures will enhance uptake of research into practice and may ultimately improve diabetes care and clinical outcomes. Along with the serial developments mentioned above, the BNHI ( the sole healthcare insurance organization in Taiwan ) has been fully involved, from the very beginning, in the formation and development of these performance measures which have totally been included in the development of the Diabetes Case Management Program ( DCMP ) 2001 later on. The DCMP 2001 is a unique program that has been delivered into the nation-wide clinical practices since Dec. 2001 in Taiwan. It has linked the quality of diabetes care to the monthly income ( reimbursed from BNHI ) of the registered clinical diabetes educators ( i.e., physicians, nurses and dietitians ) for enhancing and assuring the complete implementation of these performance measures in diabetes care. It has been recognized that a consensus on measures at national level could provide a method for assessing care within and across healthcare settings while providing a meaningful mechanism for quality improvement. In this proposal, we are going to develop the Diabetes Quality Improvement Program ( DQIP ) based on the DCMP 2001 in Taiwan.

Initially, we are going to establish the continuous diabetes quality monitoring system and then to evaluate the (1) the lifestyles and eating habits and dietary compositions in type 2 diabetes mellitus (2)The relationships between lifestyles and eating habits and dietary compositions in diabesity.

Study Overview

Status

Unknown

Conditions

Detailed Description

Diabetes is now a global epidemic; it is the fourth or fifth leading cause of death in most developed and newly industrialized countries. People with diabetes mean a long-term condition that deserves effective and efficient care throughout their lives. Complications caused by diabetes, such as coronary artery and peripheral vascular diseases, stroke, diabetic neuropathy, amputations, renal failure and blindness are resulting in increasing disability, reduced life expectancy and, even more apprehensive, enormous healthcare related expense for virtually every society ( 1, 2 ). Diabetes is certainly one of the most challenging health issues in the 21st century.

The most recent epidemiological data suggested that the diabetes population in Taiwan has reached one million ( 3 ). People with diabetes using the healthcare insurance regularly for their diabetes care, however, were only 60 % of total diabetes population. Nevertheless, this 60 % of Taiwan diabetes population had already consumed more than 12 % of total national annual healthcare expenditure in taking care of them. In fact, this diabetes population was merely one- forties of Taiwan population as a whole. Even the worst thing was that more than 60 % of the whole yearly healthcare budget for taking care of diabetes had gone into the treatment of diabetes-related complications ( 4,5 ). We have recently learned from some of the prevention trials, such as the Diabetes Control and Complications Trial ( DCCT ) in type 1 diabetes and the United Kingdom Prospective Diabetes Study ( UKPDS ) in type 2 diabetes, that effective and adequate performance of metabolic and blood pressure control in patients with diabetes would be able to delay or even prevent the diabetes-related complications ( 6-8 ). These interventions, if broadly implemented, would help to improve the living quality of diabetes patients, and as well as to consequently make the biggest gain out of healthcare expenditure ( 9 ). In order to assess more completely the levels of diabetes care delivered in Taiwan, we now have nationally standardized performance measures that can evaluate quality of diabetes care accurately and reliably. These performance measures were seriously reviewed and discussed in the aspects of their practicability, feasibility and compliancy, through a series of nation-wide consensus meetings by a number of multidisciplinary professionals of Taiwan Diabetes Care Teams ( TDCTs ), before delivering into the clinical settings ( 10 ).

Conceptually, these measures will enhance uptake of research into practice and may ultimately improve diabetes care and clinical outcomes. Along with the serial developments mentioned above, the BNHI ( the sole healthcare insurance organization in Taiwan ) has been fully involved, from the very beginning, in the formation and development of these performance measures which have totally been included in the development of the Diabetes Case Management Program ( DCMP ) 2001 later on. The DCMP 2001 is a unique program that has been delivered into the nation-wide clinical practices since Dec. 2001 in Taiwan. It has linked the quality of diabetes care to the monthly income ( reimbursed from BNHI ) of the registered clinical diabetes educators ( i.e., physicians, nurses and dietitians ) for enhancing and assuring the complete implementation of these performance measures in diabetes care. It has been recognized that a consensus on measures at national level could provide a method for assessing care within and across healthcare settings while providing a meaningful mechanism for quality improvement. In this proposal, we are going to develop the Diabetes Quality Improvement Program ( DQIP ) based on the DCMP 2001 in Taiwan.

Initially, we are going to establish the continuous diabetes quality monitoring system and then to evaluate the (1) the lifestyles and eating habits and dietary compositions in type 2 diabetes mellitus (2)The relationships between lifestyles and eating habits and dietary compositions in diabesity.

Study Type

Observational

Enrollment (Anticipated)

20000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taichung, Taiwan, 404
        • Recruiting
        • Martin M-T Fuh
        • Contact:
        • Principal Investigator:
          • Martin Fuh, MD,DMSci

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All of Diabetes Cases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Defined Population
  • Time Perspectives: Other

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

China Medical University Hospital

Investigators

  • Principal Investigator: Martin Fuh, MD,DMSci, mmtfuh@www.cmuh.org.tw

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2007

Study Completion (Anticipated)

April 1, 2008

Study Registration Dates

First Submitted

May 8, 2007

First Submitted That Met QC Criteria

May 9, 2007

First Posted (Estimate)

May 10, 2007

Study Record Updates

Last Update Posted (Estimate)

May 10, 2007

Last Update Submitted That Met QC Criteria

May 9, 2007

Last Verified

May 1, 2007

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DMR96-IRB-41

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe